Cyclerion Therapeutics Inc (CYCN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

301 BINNEY STREET CAMBRIDGE, MA 02142

Cyclerion Therapeutics is a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function. Cyclerion's lead program is CY6463, a novel, first-in-class, CNS-penetrant, sGC stimulator that modulates a key node in a fundamental CNS signaling network. The multidimensional pharmacology elicited by the stimulation of sGC has the potential to impact a broad range of CNS diseases. CY6463 has shown rapid improvement in biomarkers associated with cognitive impairment and is currently in clinical development for Alzheimer's Disease with Vascular pathology (ADv) and Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS).

Data as of 2021-06-19 12:45:16 -0400
Market Cap150.366 Million Shares Outstanding40.421 Million Avg 30-day Volume2.638 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.84 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.5486 52-week High/Low8.96 / 2.08 Next Earnings Date2021-07-29 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CYCN instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 72 75 -4.0% 26 (1.53%) 25 (1.45%) 4.0%
13F shares: 22.398 Million 21.866 Million 2.43% 12.443 Million 12.072 Million 3.08%
% Ownership 65.7711 64.3835 2.16% 36.5386 35.5447 2.8%
New Positions: 7 12 -41.67% 5 7 -28.57%
Increased Positions 27 24 12.5% 9 7 28.57%
Closed Positions 10 13 -23.08% 4 2 100.0%
Reduced Positions 16 19 -15.79% 5 4 25.0%
Total Calls 20.805 Thousand 6.802 Thousand 205.87% 20.4 Thousand 0
Total Puts 34.219 Thousand 18.506 Thousand 84.91%
PUT/CALL Ratio 1.64 2.72 -39.71% 0.0 -100.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CYCN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CYCN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

2.9 Million total shares from 7 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCGUIRE TERRANCE

  • Director
740,390 2021-06-03 1

HECHT PETER M CHIEF EXECUTIVE OFFICER

2,049,153 2021-06-03 3

SLATE PATH CAPITAL LP

GREENSPAN DAVID GERALD

  • 10% Owner
7,157,601 2021-06-03 2

DESOUZA ERROL B

0 2021-04-21 1

WRIGHT CHRISTOPHER I CHIEF MEDICAL OFFICER

42,728 2021-02-25 2

GJINO ANJEZA CHIEF FINANCIAL OFFICER

31,599 2021-02-25 2

GAULT CHERYL CHIEF OPERATING OFFICER

9,294 2021-01-01 1

CURRIE MARK G PRESIDENT AND CSO

251,648 2020-12-28 1

BUSCH ANDREAS CHIEF INNOVATION OFFICER

  • Officer
254,704 2020-11-09 2

HUYETT WILLIAM CHIEF FINANCIAL OFFICER

  • Officer
67,590 2020-11-06 1

FANUCCI MARSHA

  • Director
0 2020-06-16 0

CHURCHWELL KEVIN

  • Director
0 2020-06-16 0

CONRADES GEORGE H

  • Director
0 2020-06-16 0

ISACSON OLE

  • Director
0 2020-06-16 0

LOVELL STEPHANIE

  • Director
0 2020-06-16 0

MENDELSOHN MICHAEL

  • Director
0 2020-06-16 0

SCHULMAN AMY W

  • Director
0 2020-06-16 0

IRONWOOD PHARMACEUTICALS INC

  • 10% Owner
0 2019-03-29 0

CONSYLMAN GINA SECRETARY AND TREASURER

  • Officer
  • Director
0 2019-03-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MCGUIRE TERRANCE - Director by polaris partners viii, l.p.

2021-06-07 17:36:24 -0400 2021-06-03 P 92,831 $3.12 a 697,313 indirect -0.4878 -8.0488 4.6341 5 -8.0488 6

HECHT PETER M CHIEF EXECUTIVE OFFICER

2021-06-07 17:25:44 -0400 2021-06-03 P 823,170 $3.28 a 2,047,698 direct -0.4878 -8.0488 4.6341 5 -8.0488 6

MCGUIRE TERRANCE - Director by polaris entrepreneurs' fund viii, l.p.

2021-06-07 17:36:24 -0400 2021-06-03 P 3,322 $3.12 a 24,957 indirect -0.4878 -8.0488 4.6341 5 -8.0488 6

SLATE PATH CAPITAL LP - > 10% Owner see footnote

GREENSPAN DAVID GERALD - > 10% Owner see footnote

2021-06-07 16:05:18 -0400 2021-06-03 P 961,538 $3.12 a 7,157,601 indirect -0.4878 -8.0488 4.6341 5 -8.0488 6

HECHT PETER M CHIEF EXECUTIVE OFFICER

2021-05-10 08:45:24 -0400 2021-05-06 P 302,000 $2.43 a 1,224,528 direct 2.9197 9.854 9.854 6 0.0 1

HECHT PETER M CHIEF EXECUTIVE OFFICER

2021-05-06 21:27:00 -0400 2021-05-05 P 398,001 $2.53 a 922,528 direct -0.7246 6.5217 34.058 55.4348 26 -0.7246 2

HECHT PETER M CHIEF EXECUTIVE OFFICER

2021-05-06 21:27:00 -0400 2021-05-04 P 300,000 $2.29 a 524,527 direct -0.7246 6.5217 34.058 55.4348 26 -0.7246 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 22:15:03 UTC -0.6234 0.7034 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 21:45:03 UTC -0.624 0.704 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 21:15:03 UTC -0.624 0.704 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 20:45:03 UTC -0.6488 0.7288 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 20:15:03 UTC -0.6488 0.7288 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 19:45:03 UTC -0.6488 0.7288 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 19:15:03 UTC -0.6488 0.7288 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 18:45:03 UTC -0.7548 0.8348 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 18:15:03 UTC -0.7548 0.8348 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 17:45:03 UTC -0.7548 0.8348 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 17:15:03 UTC -0.7548 0.8348 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 16:45:02 UTC -0.7811 0.8611 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 16:15:03 UTC -0.7811 0.8611 600000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 15:45:03 UTC -0.7811 0.8611 650000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 15:15:03 UTC -0.7811 0.8611 700000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 14:45:03 UTC -0.8579 0.9379 700000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 14:15:02 UTC -0.8579 0.9379 700000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 13:45:03 UTC -0.8579 0.9379 700000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 13:15:03 UTC -0.8579 0.9379 700000
CYCLERION THERAPEUTICS INC CYCN 2021-06-21 12:45:03 UTC -0.8579 0.9379 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments